Fully automated viability and toxicity screening—A reliable all‐in‐one attempt

Abstract Background The CRISPR/Cas9 technology is nowadays a common tool for genome editing to achieve new insights into, for example, diagnostics and therapeutics in cancer and genetic disorders. Cell proliferation and anticancer drug response studies are widely used to evaluate the impact of editi...

Full description

Bibliographic Details
Published in:	Cancer Medicine
Main Authors:	Victoria Liedtke, Romano Weiss, Anastasia Skifov, Stefan Rödiger, Lysann Schenk
Format:	Article
Language:	English
Published:	Wiley 2024-06-01
Subjects:	automated system bioimage informatics CRISPR/Cas9 cytotoxicity viability
Online Access:	https://doi.org/10.1002/cam4.7392

Similar Items

A Novel Methodology for Characterizing Cell Subpopulations in Automated Time-lapse Microscopy
by: Georges Hattab, et al.
Published: (2018-02-01)

Large-scale copy number alterations are enriched for synthetic viability in BRCA1/BRCA2 tumors
by: Yingjie Zhu, et al.
Published: (2024-08-01)

Targeting Telomeres and Telomerase: Studies in Aging and Disease Utilizing CRISPR/Cas9 Technology
by: Andrew C. Brane, et al.
Published: (2019-02-01)

Anti‐CRISPRs: The natural inhibitors for CRISPR‐Cas systems
by: Fei Zhang, et al.
Published: (2019-06-01)

Eriodictyol mediated selective targeting of the TNFR1/FADD/TRADD axis in cancer cells induce apoptosis and inhibit tumor progression and metastasis
by: Shibjyoti Debnath, et al.
Published: (2022-07-01)

CRISPR genome editing and its medical applications
by: Mohammad-Reza Mahmoudian-sani, et al.
Published: (2018-03-01)

Clustered Regularly Interspaced Short Palindromic Repeats-Based Diagnostics and COVID-19; A Leap Forward in Molecular Pathology
by: Sikandar Hayat Khan
Published: (2023-10-01)

An overview of applications of CRISPR-Cas technologies in biomedical engineering
by: Saleh Jamehdor, et al.
Published: (2020-10-01)

CRISPR/Cas patents and health-related publications in South America
by: LARIANE FRÂNCIO, et al.
Published: (2023-06-01)

Current Applications and Future Perspectives of CRISPR-Cas9 for the Treatment of Lung Cancer
by: Tiruneh G/Medhin M, et al.
Published: (2021-05-01)

Novel genome-editing tools to model and correct primary immunodeficiencies
by: Lisa M Ott De Bruin, et al.
Published: (2015-05-01)

Targeted intracellular delivery of Cas13 and Cas9 nucleases using bacterial toxin-based platforms
by: Songhai Tian, et al.
Published: (2022-03-01)

Engineering CRISPR/Cas9 therapeutics for cancer precision medicine
by: Aditya Kumar Sharma, et al.
Published: (2024-04-01)

CRISPR-Cas9: A Powerful Tool to Efficiently Engineer <i>Saccharomyces cerevisiae</i>
by: João Rainha, et al.
Published: (2020-12-01)

CRISPR/Cas9 technology in the modeling of and treatment of mucopolysaccharidosis
by: Mehran Reyhani-Ardabili, et al.
Published: (2024-09-01)

Potensi kombinasi induced-pluripotent stem cells (iPSC) dan metode pengeditan gen clustered regularly interspaced short palindromic repeats–associated nuclease 9 (CRISPR-Cas9) sebagai terapi pada pasien hemofilia
by: Irfan Hasbullah Putra, et al.
Published: (2023-11-01)

CRISPR/Cas9 in Chronic Lymphocytic Leukemia
by: María Hernández-Sánchez
Published: (2022-05-01)

RNA-dependent RNA targeting by CRISPR-Cas9
by: Steven C Strutt, et al.
Published: (2018-01-01)

Characterization of CoCas9 nuclease from Capnocytophaga ochracea
by: A. Vasileva, et al.
Published: (2023-12-01)

Automated early ovarian cancer detection system based on bioinformatics
by: Li Xiao, et al.
Published: (2024-10-01)

sgRNA design and in vitro nucleolytic analysis of the Cas9‐RNP complex for transgene‐free genome editing of the eIF4E1 gene from Capsicum an‐ nuum L.
by: Josefanny Tham, et al.
Published: (2023-12-01)

Emerging Gene-editing nano-therapeutics for Cancer
by: Najma Nujoom, et al.
Published: (2024-11-01)

Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges
by: Bashdar Mahmud Hussen, et al.
Published: (2023-07-01)

Advancements in CRISPR/Cas systems for disease treatment
by: Yangsong Xu, et al.
Published: (2025-06-01)

A Review: CRISPR Cas System and the Mechanism With an Inhibition of Binding of CRISPR Cas‐9
by: Akram Hosen, et al.
Published: (2025-01-01)

CRISPR/Cas Genome Editing Technologies for Plant Improvement against Biotic and Abiotic Stresses: Advances, Limitations, and Future Perspectives
by: Yaxin Wang, et al.
Published: (2022-12-01)

Intein-mediated split SaCas9 for genome editing in plants
by: Danling Hu, et al.
Published: (2025-01-01)

CRISPR-Cas guide RNA indel analysis using CRISPResso2 with Nanopore sequencing data
by: Gus Rowan McFarlane, et al.
Published: (2024-07-01)

CRISPR-PN2: a flexible and genome-aware platform for diverse CRISPR experiments in parasitic nematodes
by: Damien M O'Halloran
Published: (2021-09-01)

Eradication of Human Immunodeficiency Virus Type-1 (HIV-1)-Infected Cells
by: Nejat Düzgüneş, et al.
Published: (2019-06-01)

Point-of-Care Testing for Infectious Diseases Based on Class 2 CRISPR/Cas Technology
by: Shiu-Jau Chen, et al.
Published: (2023-07-01)

Transient CRISPR-Cas Treatment Can Prevent Reactivation of HIV-1 Replication in a Latently Infected T-Cell Line
by: Ye Liu, et al.
Published: (2021-12-01)

Harnessing an anti-CRISPR protein for powering CRISPR/Cas9-mediated genome editing in undomesticated Bacillus strains
by: Man Su Kim, et al.
Published: (2025-06-01)

Obtaining a pancreatic cancer cell line stably expressing doxycycline-dependent endonuclease Cas9
by: A.K. Nurgalieva, et al.
Published: (2018-09-01)

Genome Editing in Zebrafish by ScCas9 Recognizing NNG PAM
by: Yunxing Liu, et al.
Published: (2021-08-01)

Comparison of CRISPR-Cas9, CRISPR-Cas12f1, and CRISPR-Cas3 in eradicating resistance genes KPC-2 and IMP-4
by: Jun Huang, et al.
Published: (2025-06-01)

Immunomodulation by Clustered Regulatory Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-Associated Protein 9
by: Duygu Kırkık, et al.
Published: (2025-03-01)

CRISPR-mediated modulation of EGFR signaling in lung cancer
by: Mobina Tabibian, et al.
Published: (2025-01-01)

Identifying in vivo genetic dependencies of melanocyte and melanoma development
by: Sarah Perlee, et al.
Published: (2025-08-01)

Nanotechnology-Based Delivery of CRISPR/Cas9 for Cancer Treatment: A Comprehensive Review
by: Mohd Ahmar Rauf, et al.
Published: (2025-07-01)